In addition, by extending our analysis to nonmalignant prostate lesions, our study is the first to reveal a significant KLK4 overexpression in nonmalignant prostate lesions (BPH, PIN and HGPIN) compared to normal prostate gland. The gene discussed is KLK4; the disease is benign prostatic hyperplasia.